1 / 34

Purchasing and Design For Patient Safety

Professor David Cousins Head of Patient Safety Medicines and Medical Devices National Patient Safety Agency London. Purchasing and Design For Patient Safety. Design For Patient Safety Series. Council of Europe Report 2007 On Safe Medication Practice.

lycoris
Download Presentation

Purchasing and Design For Patient Safety

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Professor David Cousins Head of Patient Safety Medicines and Medical Devices National Patient Safety Agency London Purchasing and Design For Patient Safety

  2. Design For Patient Safety Series

  3. Council of Europe Report 2007On Safe Medication Practice • Current European medicines regulations concerning naming, packaging and labelling for pharmaceutical products provide inadequate safeguards for patients • Medication errors frequently occur in Europe because of sound-alike or look-alike drug names, similarities in packaging and labelling appearance and unclear, ambiguous or incomplete label information

  4. Council of Europe Report 2007On Safe Medication Practice • There is little recognition of the importance of the human factor principles in selection and design of drug names, labels and packages in order to minimise the potential for error and enhance medication safety • The current design for labelling and packaging prioritise industry concerns, such as “trade dress”, instead of considering the context where the pharmaceutical product has to be used. • It is not patient-centred, but, rather, relies on an assumption of perfect performance by healthcare professionals and by patients

  5. Patient Safety Incident Involving Vaccines

  6. Minimising Risks To Patients • Facilitate correct actions • Make it easier to discover errors and take corrective action • Education, training and work competencies

  7. Procuring products that are safer to use in practice Meeting licensing standards is the minimum – practice standards may be higher Not always awarding the contract to the cheapest Products should meet the quality and safety specification – then procure at minimum cost Provide feedback to manufacturers to obtain safer products Purchasing For Safety

  8. Use Colour And Design

  9. Allocate Space for a Dispensing Label

  10. Vial Design

  11. Differentiating Injectable Products

  12. Look-a-like Names

  13. Ampoule Design

  14. Name and Strength

  15. Bar Codes

  16. Labelling of Ampoules and Syringes

  17. Technical Information

  18. Infusion Product Differentiation

  19. Screen Display

  20. Use of Colour and Design

  21. Keyboard Layout

  22. Interface Design Consistency

  23. Use of ISO Symbols

  24. Infusion Device Alarms

  25. Dose Error Reduction Software

  26. Use Of Bar Codes By Infusion Devices

  27. The ‘Universal’ Connector

  28. Safer Enteral Devices

  29. Spinal (Intrathecal), Epidural And Regional Administration Of Medicines

  30. http://www.nrls.npsa.nhs.uk

More Related